Results 51 to 60 of about 338,479 (254)

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

The human gut microbiome across the life course

open access: yesFEBS Letters, EarlyView.
Despite significant individual variation and continuous change throughout life, the human gut microbiome follows some life stage‐specific trends. This article provides a brief overview of how gut microbiome composition shifts across different phases of life. Created in BioRender. Özkurt, E. (2026) https://BioRender.com/8q4nrnc.
Alise J. Ponsero   +4 more
wiley   +1 more source

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

World Health Organization's Pathogen Access and Benefit‐Sharing system for digital sequence information and the Convention on Biological Diversity

open access: yesClinical and Translational Discovery
Background The World Health Organization Pandemic Agreement, adopted in May 2025, aims to remedy the inequities of the coronavirus disease 2019 pandemic.
WooJung Jon
doaj   +1 more source

Reconstructing enzyme evolution by protein engineering

open access: yesFEBS Letters, EarlyView.
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler   +2 more
wiley   +1 more source

Investigating the exchange of plant material between European and African botanical institutions for research and development

open access: yesPlants, People, Planet, 2023
Social Impact Statement The exchange of plant material and data is essential for supporting collaborative research efforts to address global challenges. In order to promote collaboration between Plant Genetic Resource (PGR) organizations in conservation ...
Ayenew Ashenafi   +4 more
doaj   +1 more source

Structure‐forward targeting of claudins with synthetic binders

open access: yesFEBS Letters, EarlyView.
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley   +1 more source

Changes in the Plant Treaty – How Can Benefit Sharing Happen and the Link to Intellectual Property Rights – Assessing the Mutually Supportiveness [PDF]

open access: yesLaw, Environment and Development Journal, 2015
In the discussions concerning the International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA or the ‘Plant Treaty’) often the access side takes up most of the attention.
Morten Walløe Tvedt
doaj  

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Compatible or Incompatible? DSI, Open Access and Benefit-sharing

open access: yes, 2021
The scientific community has a strong tradition of sharing digital sequence information (DSI) in an unrestricted manner through public databases. While this tradition of “open access” sharing has many benefits, it has created tension in the context of the Convention on Biological Diversity (CBD).
Sara, Rodrigo   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy